对MOG-AR得分的外部验证,用于预测MOGAD的中国队列中攻击后复发风险
Wenjing Luo1, Yiying Huang2, Yi Du3
1Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Multiple sclerosis and related disorders
|November 15, 2025
概括
MOGAD复发 (MOG-AR) 评分有效地预测了髓寡干细胞糖蛋白抗体相关疾病 (MOGAD) 的复发风险. 外部验证证实其能够识别需要更密切监测和早期治疗干预的患者.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 髓寡细胞糖蛋白抗体相关疾病 (MOGAD) 经常呈现出复发性过程.
- 早期识别高风险患者对于有效的MOGAD管理至关重要.
- MOGAD复发 (MOG-AR) 评分有助于分层攻击后复发风险.
研究的目的:
- 在独立的中国MOGAD队列中对MOG-AR得分进行外部验证.
- 评估MOG-AR得分对MOGAD患者复发的预测性能.
- 为了确认分数在指导MOGAD管理策略中的实用性.
主要方法:
- 来自中国南部的157名MOGAD患者的回顾性分析 (2015年6月至2023年5月).
- 根据年龄,性别,攻击表型和治疗持续时间计算MOG-AR得分.
- 使用C指数,校准图表和卡普兰-梅尔分析评估模型性能.
主要成果:
- 该MOG-AR得分达到0.72的C指数,表明强大的区分能力.
- 校准图表显示了有利的对齐,表明了准确的风险预测.
- 卡普兰-梅尔分析显示,MOG-AR分数组之间的复发风险存在显著差异 (p < 0.001).
结论:
- MOG-AR评分是预测中国人中MOGAD复发的验证工具.
- 该分数有效地区分和校准风险,支持其临床应用.
- 较高的MOG-AR得分与复发风险增加和复发时间缩短有关.
相关概念视频
Odds Ratio
1.5K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
1.5K
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Comparing the Survival Analysis of Two or More Groups
542
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
542


